Condition
DMD clinical trials and research
As of November 12, 2026, Find a Trial lists 7 DMD clinical trials that are recruiting, at sites in 14 countries (most in United States (3), China (1), Australia (1)). By phase: Phase 2 (2), Phase 3 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 14Countries
Newest DMD clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| VM100: a nutritional supplement to see if it improves quality of life for boys with Duchenne | Phase 2 | Gainesville, Florida | Recruiting | Aug 17, 2026 |
| Zeleciment Rostudirsen (DYNE-251) for Duchenne Muscular Dystrophy in Ambulatory Boys | Phase 3 | Hillsborough, North Carolina | Recruiting | May 27, 2026 |
| AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping | Phase 3 | Westmead, New South Wales and 19 other locations | Recruiting | May 14, 2026 |
| BBM-D101 gene therapy for boys with Duchenne muscular dystrophy | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jul 10, 2025 |
| Machine-learning multi-sensor fall risk screening for Duchenne muscular dystrophy | — | Seoul, Jongno | Recruiting | Jun 11, 2025 |
| Combining exercise and tadalafil for treating Duchenne muscular dystrophy | Phase 2 | Gainesville, Florida | Recruiting | Mar 4, 2024 |
| Registry for patients with neuromuscular disorders in Switzerland | — | Aarau, Canton of Aargau and 18 other locations | Recruiting | Nov 2, 2021 |
All recruiting trials (7)
-
VM100: a nutritional supplement to see if it improves quality of life for boys with Duchenne
This Phase 2 study tests VM100, a nutritional drink, in boys aged 8 and up with Duchenne muscular dystrophy to see if it can improve quality of life and reduce fatigue.
-
Zeleciment Rostudirsen (DYNE-251) for Duchenne Muscular Dystrophy in Ambulatory Boys
This trial tests whether intravenous Zeleciment Rostudirsen (DYNE-251) given every 4 weeks is safe and helps improve function in ambulatory boys with Duchenne muscular dystrophy who have a specific dystrophin gene mutation.
-
AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping
This study tests whether intravenous AOC 1044 helps boys with Duchenne muscular dystrophy caused by mutations amenable to exon 44 skipping.
-
BBM-D101 gene therapy for boys with Duchenne muscular dystrophy
This trial will try a single intravenous dose of BBM-D101 gene therapy in ambulatory boys aged 4 to under 9 with Duchenne muscular dystrophy to see if it is safe and helps muscle function.
-
Machine-learning multi-sensor fall risk screening for Duchenne muscular dystrophy
This project will try machine-learning and video/sensor methods to track upper limb movement and see if they can help detect fall risk in children and young adults with Duchenne muscular dystrophy.
-
Combining exercise and tadalafil for treating Duchenne muscular dystrophy
This study is testing if combining exercise with a medication called tadalafil can help boys with Duchenne muscular dystrophy improve their muscle function and blood flow.
-
Registry for patients with neuromuscular disorders in Switzerland
This study is creating a database to help people in Switzerland with neuromuscular disorders, like DMD and SMA, get access to new treatments and participate in clinical trials.
Related topics
Quick answers
How many DMD clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (3 trials), China (1 trial), Australia (1 trial), Belgium (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.